The QualityStocks Daily Friday, May 25th, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (FCSC) +354.83%

OnPointStockAlert (GMVP) +72.95%

StreetInsider (VTGN) +51.55%

The QualityStocks Daily Stock List

Kraken Robotics, Inc. (KRKNF)

Stockhouse, OTC Markets, 4-Traders, Barchart, Morningstar, InvestorsHangout, and TradingView reported on Kraken Robotics, Inc. (KRKNF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A marine technology company, Kraken Robotics, Inc.’s dedication is to the production and sale of software, sensors, and robotic systems for the international Unmanned Maritime Vehicles market. The Company’s wholly-owned subsidiary is Kraken Robotic Systems, Inc. Kraken Robotics has its headquarters in St. John’s, NL (Newfoundland and Labrador). Additionally, the Company has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia.

Kraken Robotics’ series of SAS (Synthetic Aperture Sonar) products called AquaPix® takes advantage of almost two decades of research and development (R&D) conducted by NATO’s Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a lesser cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). Moreover, it can produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Kraken Robotics has expanded from sensors to complete systems. It has introduced its KATFISH™ tethered underwater vehicle. Also, Kraken has introduced the THUNDERFISH® autonomous underwater vehicle (AUV).

Kraken also has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology. This product is for the oil and gas sector for ROVs.

The Company also has its DataPod™ product. The design of it is to meet modern data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid state storage all in one compact unit.

In addition, Kraken Robotics has its Kraken SeaVision™ system. This is a unique new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

This month, Kraken Robotics announced that its wholly-owned subsidiary, Kraken Robotic Systems, Inc., is developing an ultra-wideband acoustic remote sensing system for seafloor imaging and mapping. The AquaPix® Multispectral Synthetic Aperture Sonar (SAS) will be the world’s first commercial SAS to operate over such a broad spectrum, ranging from low audible frequencies to high ultrasonic frequencies.

Benefits of this new technology include considerably extended search range at constant high-resolution seabed pixels; and increased speed and accuracy for seabed classification and characterization. Benefits additionally include sub-bottom 3D volumetric imaging (finding objects buried beneath the seafloor).

Mr. Karl Kenny, President and Chief Executive Officer of Kraken Robotics, said, “The AquaPix® Multispectral SAS is a true gamechanger in underwater sensors and will be ideal for a wide variety of seafloor imaging and mapping applications.”

Furthermore, this month, Kraken Robotics announced that Kraken Robotic Systems successfully completed military standard certification testing of the KATFISH-M. This is a ruggedized version of Kraken Robotic’s KATFISH™ Towed Synthetic Aperture Sonar Platform.

KATFISH-M incorporates a state-of-the-art Synthetic Aperture Sonar (SAS) in a compact, lightweight and hydro-dynamically stable towed body. It utilizes advanced signal processing and algorithms to provide real-time, detection and classification against underwater mine threats.

Kraken Robotics, Inc. (KRKNF), closed Friday's trading session at $0.1164, up 1.04%, on 46,500 volume with 11 trades. The average volume for the last 60 days is 67,406 and the stock's 52-week low/high is $0.10/$0.20.

Innovation Pharmaceuticals, Inc. (IPIX)

Investors Hangout, Stockdigest Report, Stockhouse, and InvestorsHub reported on Innovation Pharmaceuticals, Inc. (IPIX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Innovation Pharmaceuticals, Inc. is a clinical stage biopharmaceutical enterprise. The Company is developing unique therapies in numerous diseases. Its belief is that it has a premier portfolio of first-in-class lead drug candidates. It is currently advancing them toward market approval, while actively seeking strategic partnerships.  Innovation Pharmaceuticals is based in Beverly, Massachusetts. 
The Company has established research collaborations with world-renowned research institutions in the U.S. and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

Innovation’s anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company has started a Phase 2 study in Ovarian Cancer. 
Innovation Pharmaceuticals’ Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and the Company more recently launched a Phase 2b study. Prurisol is a small molecule. It acts through immune modulation and PRINS reduction.  
Brilacidin, which is a defensin mimetic compound, has shown in an animal model to decrease the occurrence of severe ulcerative Oral Mucositis (OM) by greater than 94 percent versus placebo. Innovation is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Interim results have shown a marked reduction in the incidence of severe OM (WHO Grade ≥ 3). 
Brilacidin has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (superbugs). 
In addition, in a continuing Phase 2 open label Proof-of-Concept  (PoC)  trial, favorable interim results were observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two kinds of Inflammatory Bowel Disease (IBD).

Yesterday, Innovation Pharmaceuticals announced the closure of its Phase 2a clinical trial of Kevetrin for the treatment of late-stage Ovarian Cancer (OC). The Company started the trial for the purpose of demonstrating modulation of the key tumor-suppressor protein p53 that was achieved in analysis of the first patients at the lowest dose of Kevetrin.

Kevetrin (throughout pre-clinical testing and two successful clinical trials) has demonstrated promising signs of efficacy as an anti-cancer agent and a favorable pharmacokinetic profile, which includes a very short half-life and good bioavailability.


Innovation Pharmaceuticals, Inc. (IPIX), closed Friday's trading session at $0.47, up 0.43%, on 112,596 volume with 45 trades. The average volume for the last 60 days is 226,503 and the stock's 52-week low/high is $0.35/$1.17.

PetLife Pharmaceuticals, Inc. (PTLF)

RisingPennyStocks, Super Hot Penny Stocks, PennyStockMoneyTrain, WePickPennyStocks, Liquid Tycoon, Penny Stock Pick Alert, Penny Stock Pick Report, MicroCapDaily, OTCMagic, Winston Small Cap, Equity Observer, Value Penny Stocks, Jet-Life Penny Stocks, TopPennyStockMovers, PHUB News, DSR News, Winning Penny Stock Picks, Penny Stock Circle, 1-2-3 Stock Alerts, StockMister, Fortune Stock Alerts, SixFigureStockPicks, PennyPickAlerts, Super Nova Stock Picks, Joe Penny Stocks, FOX Penny Stocks, Wall St Report, smartOTC, and OTC Markets Group reported earlier on PetLife Pharmaceuticals, Inc. (PTLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

PetLife Pharmaceuticals, Inc. is a developer of new generation high potency veterinary cancer medications and nutraceuticals for pets. PetLife is a registered US Veterinary Pharmaceutical company. It is a spinoff of Medolife Corp. The Company’s management team comprises experts and professionals in the veterinary, business, sales and management fields.  OTCQB-listed, PetLife Pharmaceuticals is headquartered in Hancock, Maryland.   
The Company is launching a new generation of all natural veterinary cancer medications and nutraceuticals based on the venom of the Caribbean Blue Scorpion. The foundation of this treatment is on the same patented formula and production processes used in the human formulation called Escozine™.  
PetLife Pharmaceuticals has licensed the international rights to formulate, package, and market a new product line, "Vitalzul for Pets™".  It anticipates incorporating Vitalzul™ in a new and advanced therapeutic pet food line in 2019.  

Vitalzul™ was originally developed and commercialized by PetLife™, Corp. in 2007. PetLife™ received a full patent in 2012. The exclusive patent license is being utilized to produce a new generation of nutraceuticals and drugs using the polarized, potentiated bioactive peptide to cause apoptosis in malignant cells. Vitalzul™ sells in the U.S. as a nutraceutical.  
PetLife Pharmaceuticals announced in 2017 that its subsidiary, Dr. Geoff's by PetLife, Inc.,  completed the acquisition of assets related to the natural pet food product line. The different trademarks supporting the Dr. Geoff's Real Food for Pets™ were obtained in exchange for common stock of PetLife Pharmaceuticals. The product line is projected to include VitalZul™ in a second generation of the product this year.  
PetLife Pharmaceuticals has engaged its in-country team for the development of its PetLife Scorpion Ranch. Scorpions have been collected. Plans continue to have the ranch completely functional and extracting venom. PetLife Pharmaceuticals’ intention is to use all its production of venom on proprietary PetLife products for the treatment of cancer. It intends to continue research on Vitalzul™'s potential as a cancer preventative.

This past October, PetLife Pharmaceuticals, via its subsidiary, PetLife Pharma International, Inc., and in cooperation with Elite International Partners, announced its initiatives in Haiti to improve the lives of companion animals and the people of Haiti. With the cooperation and support of the Haitian government, and in partnership with the Mission Light of Light Church, the Company is establishing a scorpion ranch and laboratory facilities (PetLife Scorpion Ranch ™), to harvest the venom of the Caribbean Blue Scorpion. This will provide the necessary material for the Company’s research efforts and production of its patent-pending formulation for the treatment of cancer in animals and humans.

PetLife Pharmaceuticals, Inc. (PTLF), closed Friday's trading session at $0.0118, up 47.50%, on 207,395 volume with 10 trades. The average volume for the last 60 days is 241,414 and the stock's 52-week low/high is $0.001/$0.58.

TimefireVR, Inc. (TFVR)

Barchart, Stockhouse, Marketwired, InvestorsHub, MarketWatch, and Street Register reported on TimefireVR, Inc. (TFVR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

TimefireVR, Inc. is a software company with a virtual reality platform for immersive, interactive, as well as social experiential learning. The Company formed in early 2014 to develop a virtual reality application platform, Hypatia, built on pillars of social interaction, commerce, cultural immersion, and entertainment. Hypatia is a curated virtual reality destination metaverse of massive scale. 

On September 14, 2016, EnergyTek Corp. announced that it merged with Timefire LLC. The Company subsequently changed its name to TimefireVR, Inc.   A technology enterprise, TimefireVR is headquartered in Scottsdale, Arizona.  
Hypatia is influenced from some of the most visited cities in the world. TimefireVR's VR platform application provides an environment for cooperative participation and experiential learning in a safe environment. 

With Hypatia, one can socialize, talking via text or audio. One can also shop; watch videos, concerts, and plays. With Hypatia,  a user can create and customize the world about them. Additionally, a user can travel to real cities and fantasy destinations. 
In June of 2017, TimefireVR formally launched its exclusive Virtual Reality title Hypatia, its multi-player multi-hour social environment.

However, last month, TimefireVR announced shifting its main corporate emphasis towards the strategic investments in crypto currency and potential acquisitions of blockchain technology businesses. As part of the shift in strategic direction, it sold its virtual reality assets. In addition, it appointed Mr. Jonathan Read to serve as Chief Executive Officer (CEO), Secretary, and Treasurer of TimefireVR.

Mr. Read has been a Director of TimefireVR since August 18, 2017. Since July 14, 2017, he has served as a member of the Board of Directors of BTCS, Inc. (BTCS), a blockchain technology focused company.

Mr. Jonathan Read, TimefireVR’s CEO, said, “Blockchain technology and its application of crypto currencies is an amazing enabling technology paradigm that will have a profound and disruptive impact on a host of industries. I am incredibly proud of our accomplishments in virtual reality; however, the Board of Directors made a strategic decision, in the best interest of our shareholders, to leverage my experience in blockchain technology where I serve as a member of the Board of Directors of BTCS Inc. (OTC Pink:BTCS), our strategic business vision and our ability to access the capital markets immediately.”

TimefireVR announced the sale of its virtual reality assets, mainly the social media/education platform and virtual world “Hypatia” to a group of investors. This includes its original founders, Mr. John Wise and Mr. Jeffrey Rassas. The expectation is that Hypatia will be a VR destination content leader. Consistent with this sale, TimefireVR expects to change its name following Board and shareholder approval.

At first, TimefireVR will concentrate on Ethereum, which is a foremost blockchain platform for Decentralized Applications (DApps). These are applications that run on a peer-to-peer network of computers instead of on one single computer or server.  

TimefireVR, Inc. (TFVR), closed Friday's trading session at $0.0055, up 10.00%, on 4,004,104 volume with 90 trades. The average volume for the last 60 days is 3,117,423 and the stock's 52-week low/high is $0.0043/$0.185.

Envision Solar International, Inc. (EVSI)

Greenbackers, RedChip, SmarTrend Newsletters, OTCJournal,  FeedBlitz, Hotstocked,  Stock News Now, SmallCapVoice, and Stockwire reported  on Envision Solar International, Inc. (EVSI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Envision Solar International, Inc. is the leading renewably energized EV charging, outdoor media, and energy security products company.  It is a developer of solar products and proprietary technology solutions. The Company designs, manufactures, and deploys innovative, renewably energized, EV charging and media and branding systems.  Envision Solar International is headquartered in San Diego, California.

Envision Solar’s products include the patented EV ARC™ and Solar Tree® product lines. All of the Company’s products can be enhanced with EnvisionTrak™ patented solar tracking, ARC Technology™ energy storage, SunCharge™ Electric Vehicle Charging Stations,  and digital advertising packages.

  Envision Solar has designed and incorporated EnvisionTrak, its proprietary and patented tracking solution, to the Solar Tree structure. It has deployed its latest generation of Solar Tree products, the Solar Tree HVLC (High Value, Low Cost) collection.

The new Solar Tree product incorporates its latest engineering and fabrication improvements. The Company’s Solar Tree® structure works as a billboard for a company’s green credentials. This is while producing clean energy and improving the aesthetics of any parking lot.

  Envision Solar has also developed the aforementioned  EV ARC™. It has observed that the EV ARC™  (Electric Vehicle Autonomous Renewable Charger) can solve manifold problems associated with electric vehicle charging infrastructure deployments.

The EV ARC™ produces enough clean, solar electricity to power up to 225 miles of EV driving in a day. The EV ARC™ fits inside a parking space.

Last week, Envision Solar announced the order of five additional EV ARC™ products placed by the California Department of Parks and Recreation. EV ARC™ units have been successfully deployed by Parks. They are being used for workplace charging at the agency’s Bay Area District Office and public charging for park visitors at Natural Bridges State Park in Santa Cruz. The Department’s second order comes directly following the display of an EV ARC™ unit at the California State Capitol 3rd Annual AltCar Fleet Conference.

Yesterday, Envision Solar International announced the successful delivery of another EV ARC™ product to a Department of Energy (DOE) National Laboratory to provide emissions-free EV charging for its fleet vehicles. DOE National Laboratories are in the process of changing over their fleets to zero-emissions vehicles (ZEVs).

The EV ARC™ products’ ease of deployment and environmental impact-free installation, coupled with the truly emissions-free driving it delivers, were significant factors in the Lab’s decision to choose the EV ARC™ over grid-tied options.

Envision Solar International, Inc. (EVSI), closed Friday's trading session at $0.3199, up 3.19%, on 38,855 volume with 21 trades. The average volume for the last 60 days is 128,835 and the stock's 52-week low/high is $0.09/$0.429.

Bravada Gold Corp. (BGAVF)

Gold Investment Letter and Real Pennies reported on Bravada Gold Corp. (BGAVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties cover a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development.  Bravada Gold has its corporate headquarters in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

Bravada Gold retains residual working or royalty interests. It explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions. Currently, five of the Company’s Nevada properties are being funded by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.

Concerning the North Lone Mountain and South Lone Mountain projects,  plans have not been finalized for Bravada Gold’s two claim groups. Nevertheless, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada  will retain a royalty on base and precious metals.

Pertaining to its Wind Mountain project, Bravada’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization beneath the existing disseminated resource at Wind Mountain. Regarding the SF property, Bravada plans to drill-test for high-grade “Carlin-type” gold mineralization at this property.  

Recently, Bravada Gold announced that it received, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target this year. Multiple holes can be drilled from these sites. The Quito Property is positioned along the Austin Gold trend in central Nevada.

Moreover, Bravada Gold, via its wholly-owned U.S. subsidiary Bravo Alaska, Inc.,  and Yamana Gold, Inc., via its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.

The amendment will eliminate a "Claw-back" provision that allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold will receive 1,000,000 common shares in Bravada Gold and warrants to purchase 1,000,000 common shares at CDN$0.15 for a period of three years.

Bravada Gold Corp. (BGAVF), closed Friday's trading session at $0.065, even for the day. The average volume for the last 60 days is 17,979 and the stock's 52-week low/high is $0.0611/$0.1903.

Integra Resources Corp. (IRRZF)

TradingView, Penny Stock Hub, Investing News Alerts, TheHotPennyStocks, Barchart, High Rising Stocks, Stockwolf, TheProspectorNews, and Dividend Investors reported on Integra Resources Corp. (IRRZF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Integra Resources Corp. engages in the acquisition, exploration and development of mineral properties in the Americas. Its primary focus is the advancement of its DeLamar Project. The Company formerly went by the name Mag Copper Limited. It changed its corporate name to Integra Resources Corp. in August of last year. A development-stage company, Integra Resources is headquartered in Vancouver, British Columbia.

Integra Resources’ DeLamar Project consists of the neighboring DeLamar and Florida Mountain Gold and Silver Deposits in the heart of the historic Owyhee County mining district in south-western Idaho. Integra Resources is beginning this year a $10 million drill program at DeLamar.

The 2018 exploration program will include aggressive drilling, metallurgical testing, geophysical surveys, and field sampling, mapping and prospecting. In addition, it will include a technological approach to targeting.

The DeLamar Project comprises roughly 5,300 acres of patented and unpatented claims, and a further 4,100 acres of leased lands with about 1,575 historic drill holes and 145,940 meters of drilling outlined in historic databases.

Integra Resources announced this past January that it acquired a 100 percent interest in the Empire Claim Group for USD $1.6 million. The Empire Claim Group covers greater than 95 percent of the past producing Florida Mountain gold-silver Project. Integra Resources’ newly acquired interest is free of all royalties and other kinds of financial encumbrances. With the agreement, Integra Resources acquired 36 patented mining claims totaling approximately 440 acres.

Florida Mountain hosts a significant drill database consisting of more than 1,050 holes. These were primarily drilled by Kinross and NERCO to define open pitable oxide mineralization.

In March, Integra Resources announced that it filed on SEDAR the Independent National Instrument 43-101 (NI 43-101) technical report for the Florida Mountain Gold-Silver Deposit resource estimate situated in southwest Idaho. The report was posted as an update to the DeLamar Project NI 43-101 published in 2017. It is available on SEDAR and the Integra’s website.

The resource estimations for Florida Mountain and DeLamar were completed by Mine Development Associates (MDA) of Reno, Nevada. The NI 43-101 technical report filed incorporates roughly 133,000 m of historic drilling in 1,075 drill holes. The historic drilling was carried out from the 1970s to 1990s by previous operators of the site, including NERCO and Kinross Gold.

This month, Integra Resources announced initial assay results from 9 of 13 drill holes completed so far from its 2018 drill program on the DeLamar Gold and Silver Project in the historic Owyhee County mining district in south-western Idaho. Initial results demonstrate continuity of certain structures within the DeLamar Deposit. The results announced this month are from 2,903 m of drilling from the approximate 20,000 m exploration program underway this year.

Integra Resources Corp. (IRRZF), closed Friday's trading session at $0.7335, even for the day. The average volume for the last 60 days is 7,882 and the stock's 52-week low/high is $0.05/$1.83.

ASAP Expo, Inc. (ASAE)

InvestorsHub, MarketWatch, Market Exclusive, and Barchart reported on ASAP Expo, Inc. (ASAE), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

ASAP Expo, Inc. (dba ASAP International Holdings) is a holding company headquartered in Los Angeles, California. It operates real estate, investment banking, and consulting for Chinese companies. ASAP Expo’s work is to be the bridge between China and the Western world. Established in 2010, ASAP Expo lists on the OTC Markets Group’s OTCQB.

The Company, in the past few years, is one of the most active hotel buyers in the U.S. It has consulted with its clients, with successful acquisitions of more than 31 hotels, with a total value of greater than $1 Billion. ASAP Expo’s Real Estate division assists institutional and high net-worth individuals with acquisition advisory and asset management.

In essence, ASAP Expo is a worldwide investment management company. It specializes in acquisitions advisory and asset management devoted to maximizing value for a diversified equity partners base. 

ASAP previously successfully advised on the acquisition for UHON, Inc. of The Shores Resort and Spa in Daytona Beach, Florida that closed on November 1, 2016.  UHON established as a real estate development and investment company in August of 2015 in North America. 

ASAP announced in January of this year that it successfully acquired The Renaissance Woodbridge Hotel located in 515 US-1, Iselin, New Jersey, which closed on November 15, 2016. The hotel (located between Edison and Woodbridge Township) is surrounded by popular attractions. These include the Menlo Park Museum, Rutgers University, and Newark International Airport.

This past May, ASAP Expo announced the acquisition of the DoubleTree by Hilton Salt Lake City Airport hotel, located in Salt Lake City, Utah. The Plasencia Group represented Laurus Corporation in the sale of the 288-guestroom hotel to ASAP Holdings.

The DoubleTree is situated at the heart of the International Center business and manufacturing district near Salt Lake City International Airport. It is ten minutes from the city's downtown area.

Earlier in November, ASAP announced the acquisition of the Hilton Houston Galleria Area hotel, in Houston, Texas. The 293-guestroom hotel was purchased by a new joint venture between Golden Emerald LLC and ASAP. The Hotel is located less than 2 miles from the prestigious Galleria Shopping & Business District. It is j10 miles from downtown Houston. ASAP will renovate the Hotel from a Hilton to a Doubletree.

ASAP Expo, Inc. (ASAE), closed Friday's trading session at $0.455, up 28.13%, on 55,210 volume with 19 trades. The average volume for the last 60 days is 48,408 and the stock's 52-week low/high is $0.017/$0.485.

Kona Gold Solutions, Inc. (KGKG)

Penny Stock Tweets, The Street, Business Insider, SmallCapVoice, Simply Wall St, SmallCapExclusive, Stockopedia, Insider Financial, YCharts, Stockwatch, Dividend Investor, InvestorsHub, MarketWatch, OTC Markets, Barchart, 4-Traders, Investors Hangout. Information Vine, EmergingGrowth, MicroCapDaily, and PinkInvesting reported on Kona Gold Solutions, Inc. (KGKG), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp lifestyle brand focused on product development in the functional beverage sector. The Company has developed a premium Hemp Infused Energy Drink line, Energy shots, and Apparel. Kona Gold is a member of the Hemp Industries Association (HIA).

Kona Gold Solutions announced this past February that it will be moving its headquarters to Melbourne, Florida.  The Company signed a five-year lease at 746 North Drive, Suite A, Melbourne, Florida.

The new location will provide Kona Gold Solutions with 4,500 square feet of office and warehouse space. This will allow accommodations for personnel growth and product expansion for wholly-owned subsidiaries Kona Gold, LLC; HighDrate, LLC; and BitHive Mining, LLC.  Kona’s move in date is scheduled for June 1, 2018.

Kona’s HighDrate subsidiary has developed the beverage industry’s first CBD Energy Water. It is available in four flavors – Watermelon, Kiwi Strawberry, Tropical Coconut, and Georgia Peach. This subsidiary’s concentration is on consumers that lead an active lifestyle and require a balanced beverage that will meet their needs of providing their mind and body with a focused boost and fast recovery.

Kona Gold Solutions has formed a new, wholly-owned technology focused subsidiary, the aforementioned BitHive Mining, LLC. This subsidiary is to aggressively pursue cryptocurrency mining of Bitcoin and other cryptocurrencies. BitHive Mining will be exclusively focused on mining cryptocurrencies via custom built mining hardware. 

BitHive Mining will have dedicated personnel. In addition, the new initiative will have no impact on Kona Gold Solution’s chief business in the functional beverage sector.

Last month, Kona Gold Solutions announced that its wholly-owned subsidiary, BitHive Mining, brought its first crypto currency mining rig online. BitHive Mining’s first mining rig was brought online and is mining a specific crypto currency around the clock. It continues to do so, 24 hours a day, 7 days a week.  The Company plans to bring 8-10 mining rigs online in 2018, with ROI (Return on Investment) projections in the range of 6-8 months from the date of the mining rigs coming online.

Earlier this month, Kona Gold Solutions announced two new distribution deals in Bermuda and New York.  The Bermuda distribution deal marks Kona’s first distribution partner outside of the U.S. and will be exclusively distributing Kona Gold Hemp Energy Drinks on the island of Bermuda.  The Company’s new distribution partner in Upstate New York will be distributing Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters.


Kona Gold Solutions, Inc. (KGKG), closed Friday's trading session at $0.0127, down 0.78%, on 1,548,541 volume with 28 trades. The average volume for the last 60 days is 2,301,105 and the stock's 52-week low/high is $0.0027/$0.0338.

Brightlane Corp. (BTLN)

MarketWatch, InvestorsHub, OTC Markets, Simply Wall St, Stockhouse, Barchart, 4-Traders, Morningstar, GuruFocus, Capital Cube, YCharts,, Penny Stock Tweets, Market Exclusive, Marketwired, and TradingView reported on Brightlane Corp. (BTLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Brightlane Corp. is a real estate operating company listed on the OTC Markets Group’s OTCQB. The Company provides an alternative pathway to home ownership by way of a right-to-purchase program after meeting certain criteria. Brightlane concentrates on acquiring, renovating, managing, and leasing low priced single-family homes mainly in the United States. The Company has its corporate office in Houston, Texas.

Brightlane provides opportunities in the affordable housing market including reasonable rents and leases. At present, the Company acquires single-family homes and portfolios of single-family homes. It pursues the acquisition of these kinds of homes via one-off purchases, the purchase of portfolios, as well as other methods of acquisition.

Brightlane’s criteria for acquisitions of single-family home portfolios are a portfolio size of 5 to 500 homes. The Company’s acquisition efforts are chiefly focused in the Southeast, Midwest, and Southwest regions of the U.S.

Brightlane is looking for growth in ancillary markets. It is enhancing its business plan to access higher value and higher profit market segments with synergistic effects to its business model.

The Company is working to expand its business model into different areas. These areas include multifamily, active adult living, and student housing. These areas also include build-to-rent in the affordable housing space, non-performing notes, as well as credit reporting. In addition, Brightlane will be executing a ground up construction platform of rental single and multifamily products.

Mr. Steve Helm, Brightlane’s President and Chief Executive Officer, stated, "Our market segment has evolved and Brightlane is responding accordingly.  With the current market evolution and market dynamics, we have now better aligned our acquisition strategies to most effectively utilize our $5 million credit facility and gain access to additional finance."

Furthermore, Mr. Helm stated, "One of our goals for 2018, which we believe can be accomplished this calendar year by adhering to our acquisition and corporate development initiatives, is to apply for admission to the NASDAQ Exchange."

Brightlane Corp. (BTLN), closed Friday's trading session at $1.30, up 42.08%, on 134,900 volume with 23 trades. The average volume for the last 60 days is 3,651 and the stock's 52-week low/high is $0.86/$4.25.

Emblem Corp. (EMMBF)

Stockhouse, New Cannabis Ventures, Stockwatch, Proactive Investors, InvestorsHub, Insider Financial, Micro Cap Research, 4-Traders, Marijuana Stocks, The Street, Penny Stock Tweets, Daily Marijuana Observer, CannabisNewsBreaks, Profit Confidential, TipRanks, WalletInvestor, PotNetwork, and Cannabis Stock Picks reported on Emblem Corp. (EMMBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Emblem Corp., via its wholly-owned subsidiary, Emblem Cannabis Corporation, is a fully integrated LP (Licensed Producer) and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The Company has three distinct verticals. These are cannabis production, patient education centers, as well as pharmaceutical dosage form development. Emblem has its head office in Toronto, Ontario.

The Company has its Paris, Ontario facility. The new Paris facility was custom-designed and purpose-built specifically to cultivate and cure cannabis for medicinal use. This facility has a planned expansion to 17,000KG of annual production.

Emblem’s three businesses encompass the full cannabis spectrum. This is from growing, to selling, to educating, to creating new forms of cannabinoid-based medication in standardized dosages.

Emblem Cannabis is a team of passionate growers. Their commitment is to cultivating cannabis strains in their purest expression.

The Company also has its Emblem Pharmaceutical. Mr. John Stewart, Chief Executive Officer of the Emblem Pharmaceutical Division, said, “…Emblem is identifying the cannabis strains with the greatest evidence of benefit in various conditions, cultivating those strains at medical grade and developing advanced dosage forms to provide patients with accurate, consistent, high quality and convenient to use cannabis formulations.”

Furthermore, Emblem has its GrowWise Health division. GrowWise’s commitment is to providing patients and physicians with complimentary, personalized, education services to make informed decisions concerning medical cannabis treatment options.

Earlier this month, Emblem and Canntab Therapeutics Limited announced the receipt of Health Canada approval for research and development (R&D) activities on oral sustained release formulations of cannabinoids that are the proprietary products conceived by Canntab Therapeutics representing major progress in Emblem and Canntab’s partnership to develop long-acting cannabis formulations.

Canntab Therapeutics is a Canadian cannabis oral dosage formulation company headquartered in Markham Ontario. It engages in R&D of advanced pharmaceutical grade formulations of cannabinoids.

Canntab Therapeutics brought development and processing equipment to Emblem’s Paris, Ontario location. Canntab started making the initial pivotal batch of the Product this month employing its patented technology and proprietary processes.

The first batch will undergo rigorous testing internally by Emblem and Canntab Therapeutics and externally by third-party laboratories. Upon attainment of the Product‘s target design criteria, Emblem and Canntab’s intention is to submit a full dossier to Health Canada for review and approval.

Emblem Corp. (EMMBF), closed Friday's trading session at $1.17, down 0.85%, on 126,197 volume with 123 trades. The average volume for the last 60 days is 167,144 and the stock's 52-week low/high is $0.9297/$2.21.

LexaGene Holdings, Inc. (LXXGF)

Pinnacle Digest, Stockwatch, YCharts,, The Street, OTC Markets, Dividend Investor, Insider Financial, MarketWatch, Stockhouse, Capital Cube, Barchart, Investor Place, Financial Trends, and Markets Insider reported on LexaGene Holdings, Inc. (LXXGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

LexaGene Holdings, Inc. develops instrumentation for pathogen detection. The Company is developing the LX6, which is the very first fully automated pathogen detection platform that is open-access.  This open-access feature will enable end-users to target any pathogen of interest, as they can load their own real-time PCR assays onto the instrument for customized pathogen detection. A biotechnology company, LexaGene Holdings is based in Beverly, Massachusetts.

The Company is working to change the pathogen detection landscape through providing a customizable sample-to-answer instrument that is more rapid and sensitive than anything now available. LexaGene is working to transform the way pathogen testing is performed by multi-billion dollar industries. These industries include food safety, veterinary diagnostics, water quality management, aquaculture farming, and more.

The Company has strategic relationships with Boston Engineering – a development partner; and also the Lawrence Livermore National Laboratory. The Company’s Microfluidic Technology is open access - users can load standard pathogen specific assays onto the instrument for customized testing.

A feature of this technology is extreme sensitivity. The flow-through instrument processes large sample volumes to maximize the chances of detecting ultra-rare pathogens. The Microfluidic Technology features low cost per test and it is user-friendly.

In April, LexaGene Holdings announced that it entered into collaboration with Ethos Veterinary Health. Ethos is a veterinary health company with hospitals throughout the United States that provide advanced medical care for pets.

The partnership will provide canine urine samples to LexaGene for testing on the Company’s LX6 prototype for more effective, fast, as well as on-site pathogen detection. The samples were earlier characterized using conventional technologies (MALDI-TOF/mass spectrometry) at its reference laboratory.

This month, with the recent outbreaks associated with romaine lettuce (E. coli) and eggs (Salmonella) in the headlines, LexaGene Holdings announced that its prototype for more effective pathogen detection is now generating data. This includes the ability to identify E. coli and Staph.

The design of this technology is for healthcare providers and food safety officers to use at their facilities for pathogen detection. The technology can process six samples at a time – searching for more than 22 pathogens – and return results in approximately one hour.

LexaGene Holdings, Inc. (LXXGF), closed Friday's trading session at $0.9594, down 0.49%, on 13,764 volume with 26 trades. The average volume for the last 60 days is 33,345 and the stock's 52-week low/high is $0.3978/$1.285.

The QualityStocks Company Corner

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

CannabisNewsAudio announces the Audio Press Release (APR) titled "Opportunities for Growth Found in Burgeoning Cannabis Industry," featuring Global Payout, Inc. (OTC Pink: GOHE). To hear the NetworkNewsAudio version, visit To read the original editorial, visit

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0168, up 7.69%, on 5,045,769 volume with 138 trades. The average volume for the last 60 days is 9,788,125 and the stock's 52-week low/high is $0.0099/$0.16.

Recent News

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields as well as medical devices and research and development, is poised to gain its share of the ever-growing cannabis sector. To view the full article, visit:

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.74, up 6.47%, on 31,613 volume with 14 trades. The average volume for the last 60 days is 15,078 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC:REFG), a Nevada corporation specializing in state-of-the-art financial services structured to serve the medical cannabis and banking industries, today announces it has acquired two marijuana strains, GrapeApe and Birthday Cake, from the strains’ creator.  GrapeApe is an indica strain that has tested at approximately 33 percent THC by volume. 

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0698, up 7.38%, on 1,727,830 volume with 170 trades. The average volume for the last 60 days is 472,420 and the stock's 52-week low/high is $0.0161/$0.0977.

Recent News

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF)  plans to release its results for the first quarter 2018, after market close on Wednesday, May 30, 2018.

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $5.9362, up 1.30%, on 23,302 volume with 97 trades. The average volume for the last 60 days is 35,084 and the stock's 52-week low/high is $5.86/$16.00.

Recent News

The Green Organic Dutchman (TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) is setting a new standard for cannabis production. Based in Hamilton, Ontario, the company is one of only three out of 104 licensed Canadian cannabis cultivators that grow the product organically.

The Green Organic Dutchman (TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TGODF), closed the day's trading session at $3.18, up 1.29%, 89,705 volume with 167 trades. The average volume for the last 60 days is 34,133 and the stock's 52-week low/high is $2.784/$3.775.

Recent News

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America Inc. (OTC:MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name “hempSMART™”, an affiliate marketing program to promote and sell its products, as well as leasing of real property and expansion of business into ancillary areas of the legalized cannabis and hemp industry.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0326, up 1.24%, on 4,543,112 volume with 306 trades. The average volume for the last 60 days is 4,734,791 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. To view the full article, visit:

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.60, even for the day. The average volume for the last 60 days is 1,261 and the stock's 52-week low/high is $0.70/$8.50.

Recent News

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX-V:LITH) (OTC:LTMCF), a Canadian company advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.66, off by 1.70%, on 700 volume with 3 trades.. The average volume for the last 60 days is 1,563 and the stock's 52-week low/high is $0.6599/$0.9021.

Recent News (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) CEO Warren Wang reported on company progress from New York City today on MoneyTV with Donald Baillargeon. The television program can be viewed online at

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.475, off by 2.06%, on 27,869 volume with 24 trades. The average volume for the last 60 days is 56,762 and the stock's 52-week low/high is $0.40/$1.58.

Recent News

BLOCKStrain Technology Corp. (TSXV: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

Blockstrain Technology Corp. (TSX-V:DNAX) strategic investment highlighted in Internet of Things Inc. (TSX VENTURE:ITT) (OTC:INOTF) (FRANKFURT:71T) corporate update, detailing its recently accomplished milestones and current growth initiatives.

BLOCKStrain Technology Corp. (TSX.V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.


BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.


BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.


BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $1.09, up 0.93%, on 51,370 volume. The stock's 52-week low/high is $0.10/$1.20.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTCQB:SING), a client of NNW focused on acquiring companies that will benefit from the injection of growth capital and technology integration. To view the full publication, titled “Supreme Court Decision Empowers States to Take Action on Sports Betting,” visit: Singlepoint was also featured this week on MoneyTV with Donald Baillargeon. To view the full interview, visit: To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.02715, off by 4.40%, on 5,712,405 volume with 237 trades. The average volume for the last 60 days is 8,556,873 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News

Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR)

The QualityStocks Daily Newsletter would like to spotlight Hammer Fiber Optic Holdings Corp. (HMMR).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Everything Wireless Approach Key to Capturing Nascent 5G Market," featuring Hammer Fiber Optics Holdings Corp. (OTCQB: HMMR). To hear the NetworkNewsAudio version, visit To read the original editorial, visit

Hammer Fiber Optic Holdings Corp. (HMMR), with headquarters in New Jersey, is a telecommunications company investing in the future of wireless technology. The company’s holdings include Hammer Fiber Optic Investments, Ltd., D/B/A Hammer Fiber, an Internet Service Provider (ISP) that offers internet, voice, video and data services in New Jersey as well as carrier services in Philadelphia and New York. Hammer Fiber serves residential and small business markets with high-capacity broadband, voice and video through direct fiber as well as its wireless fiber platform – Hammer Wireless® AIR technology.

Hammer Fiber recently completed the initial development phase of its advanced LTE fixed wireless system, which was designed and built upon its successfully deployed wireless technology suite. The expansion allows Hammer Fiber to add ultra-high capacity cellular broadband applications to its product portfolio including wholesale services such as backhaul support for cellular network operators. Designed to complement Hammer Fiber’s core business of home residential service, the company expects this latest innovation to help position Hammer Fiber as a leader in future 5G technology. The company intends to leverage the Fixed LTE system in conjunction with its already deployed Fixed Wireless DOCSIS 3.1 system to deliver on one of its core promises, to deliver high capacity broadband to markets across the country at dramatically lower cost than traditional wireline methods, including fiber. Live field testing of the new system begins in early 2018 in the U.S. with service availability to follow later in the year.

Hammer Fiber has also expanded its IaaS (Infrastructure-as-a-Service) cloud services to include support for the cryptocurrency and blockchain industry. Interested companies will be able to host their products over Hammer Fiber’s robust and modern server infrastructure, fiber network architecture and data center presence in some of the most secure locations in the New York, New Jersey and Philadelphia regions. Hammer Fiber’s servers feature best-in-class computing power, designed to allow enterprise businesses to reap the benefits of utilizing a cloud-based system without the massive cost of establishing or maintaining a corporate data center.

“Distributed architecture infrastructure, such as those utilized by blockchain entities mining cryptocurrencies or other new vertical markets utilizing blockchain technology, are growing exponentially and we are poised to fulfill a critical but fundamental need of this explosive new industry,” said Mark Stogdill, CEO of Hammer Fiber. “The distributed ledger architectures that blockchains are built on require secure and robust data processing networks, highly scalable power generation and a reliable fiber optic backbone infrastructure linking up data centers worldwide for them to exist, and that is what we at Hammer Fiber do really well.”

Hammer Fiber seeks to achieve its vision by employing an extremely qualified group of business professionals with diverse backgrounds and successful track records from a variety of related industries. HMMR’s seasoned leadership team combines startup expertise with a consummate understanding of the regional competitive telecommunications landscape in sales, marketing, engineering, construction and business development.

Hammer Fiber Optic Holdings Corp. (HMMR), closed the day's trading session at $1.40, off by 10.26%, on 55,953 volume with 48 trades. The average volume for the last 60 days is 6,865 and the stock's 52-week low/high is $1.22/$48.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.